Loading…

Systematic analysis of mucosal‐associated invariant T cells in haematological malignancies

Mucosal‐associated invariant T‐cells (MAIT) are unconventional T‐cells with cytotoxic and pro‐inflammatory properties. Previous research has reported contradictory findings on their role in cancerogenesis with data being even scarcer in haematological malignancies. Here, we report the results of a s...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian journal of immunology 2024-06, Vol.99 (6), p.e13364-n/a
Main Authors: Bacova, Barbora, Cierny, Jakub, Nemcekova, Lucia, Smetanova/Brozova, Jitka, Novak, Jan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3134-3b936aa8f3a95068ce740dcee5d572c2fccc3a043383129fe13e873a3e7e5e943
container_end_page n/a
container_issue 6
container_start_page e13364
container_title Scandinavian journal of immunology
container_volume 99
creator Bacova, Barbora
Cierny, Jakub
Nemcekova, Lucia
Smetanova/Brozova, Jitka
Novak, Jan
description Mucosal‐associated invariant T‐cells (MAIT) are unconventional T‐cells with cytotoxic and pro‐inflammatory properties. Previous research has reported contradictory findings on their role in cancerogenesis with data being even scarcer in haematological malignancies. Here, we report the results of a systematic analysis of MAIT cells in treatment‐naïve patients with a broad range of haematological malignancies. We analysed peripheral blood of 204 patients and 50 healthy subjects. The pool of haematological patients had a statistically significant lower both the absolute value (median values, 0.01 × 109/L vs. 0.05 × 109/L) of MAIT cells and their percentage (median values 0.94% vs. 2.56%) among T‐cells compared to the control group. Separate analysis showed that the decrease in the absolute number of MAIT cells is significant in patients with acute myeloid leukaemia, myeloproliferative neoplasms, plasma cell myeloma, B‐cell non‐Hodgkin lymphomas, otherwise not specified, diffuse large B‐cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma compared to the control population. Furthermore, in haematological malignancies, MAIT cells overexpress PD‐1 (average values, 51.7% vs. 6.7%), HLA‐DR (average values, 40.2% vs. 7%), CD38 (average values, 25.9% vs. 4.9%) and CD69 (average values, 40.2% vs. 9.2%). Similar results were obtained when comparing patients with individual malignancies to the control population. Our data show that the depletion of circulating MAIT cells is a common observation in a broad spectrum of haematological malignancies. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype. Circulating Mucosal‐associated invariant T‐cells (MAIT) cells are significantly depleted in a broad spectrum of treatment‐naïve haematological malignancies compared to sex and age‐matched healthy subjects. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype characterized by higher expression of HLA‐DR, CD69, CD38 and PD‐1.
doi_str_mv 10.1111/sji.13364
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3053135661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3053135661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3134-3b936aa8f3a95068ce740dcee5d572c2fccc3a043383129fe13e873a3e7e5e943</originalsourceid><addsrcrecordid>eNp1kM1KxDAQx4Moun4cfAEpeNFDNek0_TjK4ieCB_UmlDE71Sxpo51W2ZuP4DP6JGZd9SCYy0D4zX9mfkJsK3mgwjvkqT1QAFm6JEYKMh2DLGBZjCRIGZdprtfEOvNUSgVJDqtiDYo8kTpRI3F3PeOeGuytibBFN2PLka-jZjCe0X28vSOzNxZ7mkS2fcHOYttHN5Eh5zj8RI84b_fOP1iDLmrQ2YcWW2OJN8VKjY5p67tuiNuT45vxWXx5dXo-PrqMDShIY7gvIUMsasBSy6wwlKdyYoj0ROeJSWpjDKBMAQpQSVmTAipyQKCcNJUpbIi9Re5T558H4r5qLM8XxJb8wBVIHQbpLFMB3f2DTv3QhcO_qATS4KUI1P6CMp1n7qiunjrbYDerlKzmyqugvPpSHtid78ThvqHJL_njOACHC-DVOpr9n1RdX5wvIj8Bvw6L9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3052342058</pqid></control><display><type>article</type><title>Systematic analysis of mucosal‐associated invariant T cells in haematological malignancies</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Bacova, Barbora ; Cierny, Jakub ; Nemcekova, Lucia ; Smetanova/Brozova, Jitka ; Novak, Jan</creator><creatorcontrib>Bacova, Barbora ; Cierny, Jakub ; Nemcekova, Lucia ; Smetanova/Brozova, Jitka ; Novak, Jan</creatorcontrib><description>Mucosal‐associated invariant T‐cells (MAIT) are unconventional T‐cells with cytotoxic and pro‐inflammatory properties. Previous research has reported contradictory findings on their role in cancerogenesis with data being even scarcer in haematological malignancies. Here, we report the results of a systematic analysis of MAIT cells in treatment‐naïve patients with a broad range of haematological malignancies. We analysed peripheral blood of 204 patients and 50 healthy subjects. The pool of haematological patients had a statistically significant lower both the absolute value (median values, 0.01 × 109/L vs. 0.05 × 109/L) of MAIT cells and their percentage (median values 0.94% vs. 2.56%) among T‐cells compared to the control group. Separate analysis showed that the decrease in the absolute number of MAIT cells is significant in patients with acute myeloid leukaemia, myeloproliferative neoplasms, plasma cell myeloma, B‐cell non‐Hodgkin lymphomas, otherwise not specified, diffuse large B‐cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma compared to the control population. Furthermore, in haematological malignancies, MAIT cells overexpress PD‐1 (average values, 51.7% vs. 6.7%), HLA‐DR (average values, 40.2% vs. 7%), CD38 (average values, 25.9% vs. 4.9%) and CD69 (average values, 40.2% vs. 9.2%). Similar results were obtained when comparing patients with individual malignancies to the control population. Our data show that the depletion of circulating MAIT cells is a common observation in a broad spectrum of haematological malignancies. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype. Circulating Mucosal‐associated invariant T‐cells (MAIT) cells are significantly depleted in a broad spectrum of treatment‐naïve haematological malignancies compared to sex and age‐matched healthy subjects. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype characterized by higher expression of HLA‐DR, CD69, CD38 and PD‐1.</description><identifier>ISSN: 0300-9475</identifier><identifier>EISSN: 1365-3083</identifier><identifier>DOI: 10.1111/sji.13364</identifier><identifier>PMID: 38720521</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Acute myeloid leukemia ; ADP-ribosyl Cyclase 1 - immunology ; ADP-ribosyl Cyclase 1 - metabolism ; Adult ; Aged ; Aged, 80 and over ; Antigens, CD - metabolism ; Antigens, Differentiation, T-Lymphocyte - metabolism ; Blood cancer ; CD38 antigen ; CD69 antigen ; Cytotoxicity ; Female ; haematological malignancies ; Hematologic Neoplasms - immunology ; Hematology ; Humans ; Immunophenotyping ; immunosenescence ; Inflammation ; Lectins, C-Type ; Lymphocyte Count ; Lymphocytes T ; Lymphoma ; MAIT cells ; Male ; Malignancy ; Mantle cell lymphoma ; Membrane Glycoproteins - immunology ; Middle Aged ; Mucosa ; Mucosal-Associated Invariant T Cells - immunology ; Myeloma ; Peripheral blood ; Phenotypes ; Programmed Cell Death 1 Receptor - immunology ; Programmed Cell Death 1 Receptor - metabolism ; Statistical analysis ; Young Adult</subject><ispartof>Scandinavian journal of immunology, 2024-06, Vol.99 (6), p.e13364-n/a</ispartof><rights>2024 The Scandinavian Foundation for Immunology.</rights><rights>Copyright © 2024 The Scandinavian Foundation for Immunology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3134-3b936aa8f3a95068ce740dcee5d572c2fccc3a043383129fe13e873a3e7e5e943</cites><orcidid>0000-0003-0029-2157 ; 0000-0003-1241-1635</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38720521$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bacova, Barbora</creatorcontrib><creatorcontrib>Cierny, Jakub</creatorcontrib><creatorcontrib>Nemcekova, Lucia</creatorcontrib><creatorcontrib>Smetanova/Brozova, Jitka</creatorcontrib><creatorcontrib>Novak, Jan</creatorcontrib><title>Systematic analysis of mucosal‐associated invariant T cells in haematological malignancies</title><title>Scandinavian journal of immunology</title><addtitle>Scand J Immunol</addtitle><description>Mucosal‐associated invariant T‐cells (MAIT) are unconventional T‐cells with cytotoxic and pro‐inflammatory properties. Previous research has reported contradictory findings on their role in cancerogenesis with data being even scarcer in haematological malignancies. Here, we report the results of a systematic analysis of MAIT cells in treatment‐naïve patients with a broad range of haematological malignancies. We analysed peripheral blood of 204 patients and 50 healthy subjects. The pool of haematological patients had a statistically significant lower both the absolute value (median values, 0.01 × 109/L vs. 0.05 × 109/L) of MAIT cells and their percentage (median values 0.94% vs. 2.56%) among T‐cells compared to the control group. Separate analysis showed that the decrease in the absolute number of MAIT cells is significant in patients with acute myeloid leukaemia, myeloproliferative neoplasms, plasma cell myeloma, B‐cell non‐Hodgkin lymphomas, otherwise not specified, diffuse large B‐cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma compared to the control population. Furthermore, in haematological malignancies, MAIT cells overexpress PD‐1 (average values, 51.7% vs. 6.7%), HLA‐DR (average values, 40.2% vs. 7%), CD38 (average values, 25.9% vs. 4.9%) and CD69 (average values, 40.2% vs. 9.2%). Similar results were obtained when comparing patients with individual malignancies to the control population. Our data show that the depletion of circulating MAIT cells is a common observation in a broad spectrum of haematological malignancies. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype. Circulating Mucosal‐associated invariant T‐cells (MAIT) cells are significantly depleted in a broad spectrum of treatment‐naïve haematological malignancies compared to sex and age‐matched healthy subjects. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype characterized by higher expression of HLA‐DR, CD69, CD38 and PD‐1.</description><subject>Acute myeloid leukemia</subject><subject>ADP-ribosyl Cyclase 1 - immunology</subject><subject>ADP-ribosyl Cyclase 1 - metabolism</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antigens, CD - metabolism</subject><subject>Antigens, Differentiation, T-Lymphocyte - metabolism</subject><subject>Blood cancer</subject><subject>CD38 antigen</subject><subject>CD69 antigen</subject><subject>Cytotoxicity</subject><subject>Female</subject><subject>haematological malignancies</subject><subject>Hematologic Neoplasms - immunology</subject><subject>Hematology</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>immunosenescence</subject><subject>Inflammation</subject><subject>Lectins, C-Type</subject><subject>Lymphocyte Count</subject><subject>Lymphocytes T</subject><subject>Lymphoma</subject><subject>MAIT cells</subject><subject>Male</subject><subject>Malignancy</subject><subject>Mantle cell lymphoma</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Middle Aged</subject><subject>Mucosa</subject><subject>Mucosal-Associated Invariant T Cells - immunology</subject><subject>Myeloma</subject><subject>Peripheral blood</subject><subject>Phenotypes</subject><subject>Programmed Cell Death 1 Receptor - immunology</subject><subject>Programmed Cell Death 1 Receptor - metabolism</subject><subject>Statistical analysis</subject><subject>Young Adult</subject><issn>0300-9475</issn><issn>1365-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kM1KxDAQx4Moun4cfAEpeNFDNek0_TjK4ieCB_UmlDE71Sxpo51W2ZuP4DP6JGZd9SCYy0D4zX9mfkJsK3mgwjvkqT1QAFm6JEYKMh2DLGBZjCRIGZdprtfEOvNUSgVJDqtiDYo8kTpRI3F3PeOeGuytibBFN2PLka-jZjCe0X28vSOzNxZ7mkS2fcHOYttHN5Eh5zj8RI84b_fOP1iDLmrQ2YcWW2OJN8VKjY5p67tuiNuT45vxWXx5dXo-PrqMDShIY7gvIUMsasBSy6wwlKdyYoj0ROeJSWpjDKBMAQpQSVmTAipyQKCcNJUpbIi9Re5T558H4r5qLM8XxJb8wBVIHQbpLFMB3f2DTv3QhcO_qATS4KUI1P6CMp1n7qiunjrbYDerlKzmyqugvPpSHtid78ThvqHJL_njOACHC-DVOpr9n1RdX5wvIj8Bvw6L9A</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Bacova, Barbora</creator><creator>Cierny, Jakub</creator><creator>Nemcekova, Lucia</creator><creator>Smetanova/Brozova, Jitka</creator><creator>Novak, Jan</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0029-2157</orcidid><orcidid>https://orcid.org/0000-0003-1241-1635</orcidid></search><sort><creationdate>202406</creationdate><title>Systematic analysis of mucosal‐associated invariant T cells in haematological malignancies</title><author>Bacova, Barbora ; Cierny, Jakub ; Nemcekova, Lucia ; Smetanova/Brozova, Jitka ; Novak, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3134-3b936aa8f3a95068ce740dcee5d572c2fccc3a043383129fe13e873a3e7e5e943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acute myeloid leukemia</topic><topic>ADP-ribosyl Cyclase 1 - immunology</topic><topic>ADP-ribosyl Cyclase 1 - metabolism</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antigens, CD - metabolism</topic><topic>Antigens, Differentiation, T-Lymphocyte - metabolism</topic><topic>Blood cancer</topic><topic>CD38 antigen</topic><topic>CD69 antigen</topic><topic>Cytotoxicity</topic><topic>Female</topic><topic>haematological malignancies</topic><topic>Hematologic Neoplasms - immunology</topic><topic>Hematology</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>immunosenescence</topic><topic>Inflammation</topic><topic>Lectins, C-Type</topic><topic>Lymphocyte Count</topic><topic>Lymphocytes T</topic><topic>Lymphoma</topic><topic>MAIT cells</topic><topic>Male</topic><topic>Malignancy</topic><topic>Mantle cell lymphoma</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Middle Aged</topic><topic>Mucosa</topic><topic>Mucosal-Associated Invariant T Cells - immunology</topic><topic>Myeloma</topic><topic>Peripheral blood</topic><topic>Phenotypes</topic><topic>Programmed Cell Death 1 Receptor - immunology</topic><topic>Programmed Cell Death 1 Receptor - metabolism</topic><topic>Statistical analysis</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bacova, Barbora</creatorcontrib><creatorcontrib>Cierny, Jakub</creatorcontrib><creatorcontrib>Nemcekova, Lucia</creatorcontrib><creatorcontrib>Smetanova/Brozova, Jitka</creatorcontrib><creatorcontrib>Novak, Jan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bacova, Barbora</au><au>Cierny, Jakub</au><au>Nemcekova, Lucia</au><au>Smetanova/Brozova, Jitka</au><au>Novak, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systematic analysis of mucosal‐associated invariant T cells in haematological malignancies</atitle><jtitle>Scandinavian journal of immunology</jtitle><addtitle>Scand J Immunol</addtitle><date>2024-06</date><risdate>2024</risdate><volume>99</volume><issue>6</issue><spage>e13364</spage><epage>n/a</epage><pages>e13364-n/a</pages><issn>0300-9475</issn><eissn>1365-3083</eissn><abstract>Mucosal‐associated invariant T‐cells (MAIT) are unconventional T‐cells with cytotoxic and pro‐inflammatory properties. Previous research has reported contradictory findings on their role in cancerogenesis with data being even scarcer in haematological malignancies. Here, we report the results of a systematic analysis of MAIT cells in treatment‐naïve patients with a broad range of haematological malignancies. We analysed peripheral blood of 204 patients and 50 healthy subjects. The pool of haematological patients had a statistically significant lower both the absolute value (median values, 0.01 × 109/L vs. 0.05 × 109/L) of MAIT cells and their percentage (median values 0.94% vs. 2.56%) among T‐cells compared to the control group. Separate analysis showed that the decrease in the absolute number of MAIT cells is significant in patients with acute myeloid leukaemia, myeloproliferative neoplasms, plasma cell myeloma, B‐cell non‐Hodgkin lymphomas, otherwise not specified, diffuse large B‐cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma compared to the control population. Furthermore, in haematological malignancies, MAIT cells overexpress PD‐1 (average values, 51.7% vs. 6.7%), HLA‐DR (average values, 40.2% vs. 7%), CD38 (average values, 25.9% vs. 4.9%) and CD69 (average values, 40.2% vs. 9.2%). Similar results were obtained when comparing patients with individual malignancies to the control population. Our data show that the depletion of circulating MAIT cells is a common observation in a broad spectrum of haematological malignancies. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype. Circulating Mucosal‐associated invariant T‐cells (MAIT) cells are significantly depleted in a broad spectrum of treatment‐naïve haematological malignancies compared to sex and age‐matched healthy subjects. In addition to their reduced numbers, MAIT cells acquire an activated/exhausted phenotype characterized by higher expression of HLA‐DR, CD69, CD38 and PD‐1.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38720521</pmid><doi>10.1111/sji.13364</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0029-2157</orcidid><orcidid>https://orcid.org/0000-0003-1241-1635</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0300-9475
ispartof Scandinavian journal of immunology, 2024-06, Vol.99 (6), p.e13364-n/a
issn 0300-9475
1365-3083
language eng
recordid cdi_proquest_miscellaneous_3053135661
source Wiley-Blackwell Read & Publish Collection
subjects Acute myeloid leukemia
ADP-ribosyl Cyclase 1 - immunology
ADP-ribosyl Cyclase 1 - metabolism
Adult
Aged
Aged, 80 and over
Antigens, CD - metabolism
Antigens, Differentiation, T-Lymphocyte - metabolism
Blood cancer
CD38 antigen
CD69 antigen
Cytotoxicity
Female
haematological malignancies
Hematologic Neoplasms - immunology
Hematology
Humans
Immunophenotyping
immunosenescence
Inflammation
Lectins, C-Type
Lymphocyte Count
Lymphocytes T
Lymphoma
MAIT cells
Male
Malignancy
Mantle cell lymphoma
Membrane Glycoproteins - immunology
Middle Aged
Mucosa
Mucosal-Associated Invariant T Cells - immunology
Myeloma
Peripheral blood
Phenotypes
Programmed Cell Death 1 Receptor - immunology
Programmed Cell Death 1 Receptor - metabolism
Statistical analysis
Young Adult
title Systematic analysis of mucosal‐associated invariant T cells in haematological malignancies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A50%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systematic%20analysis%20of%20mucosal%E2%80%90associated%20invariant%20T%20cells%20in%20haematological%20malignancies&rft.jtitle=Scandinavian%20journal%20of%20immunology&rft.au=Bacova,%20Barbora&rft.date=2024-06&rft.volume=99&rft.issue=6&rft.spage=e13364&rft.epage=n/a&rft.pages=e13364-n/a&rft.issn=0300-9475&rft.eissn=1365-3083&rft_id=info:doi/10.1111/sji.13364&rft_dat=%3Cproquest_cross%3E3053135661%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3134-3b936aa8f3a95068ce740dcee5d572c2fccc3a043383129fe13e873a3e7e5e943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3052342058&rft_id=info:pmid/38720521&rfr_iscdi=true